Skip to Main Content

Paper Details

Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
J Clin Epidemiol
2
2023
Author NameAffiliation
Nancy J ButcherThe Hospital for Sick Children Research Institute, University of Toronto
Gary S CollinsUniversity of Oxford
Dalia DawoudNational Institute for Health and Care Excellence
Martin OffringaThe Hospital for Sick Children Research Institute, University of Toronto
Joseph S RossYale School of Public Health, Yale School of Medicine
  • 1 - 5

Datasets

Release 1.2